How does anticoagulant therapy impact patient outcomes during extracorporeal membrane oxygenation (ECMO), and what considerations guide its safe administration?
Gaurav ChauhanContributor
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Anticoagulant therapy during ECMO prevents clot formation, enhancing circuit lifespan and treatment efficacy. Titration, vigilant monitoring, and balancing bleeding risks are key.